CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 15 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,725,631 | -27.5% | 6,991,003 | 0.0% | 0.11% | -24.2% |
| Q2 2023 | $7,899,833 | +13.0% | 6,991,003 | 0.0% | 0.15% | -5.7% |
| Q1 2023 | $6,990,304 | +15.2% | 6,991,003 | 0.0% | 0.16% | +28.5% |
| Q4 2022 | $6,066,792 | -32.7% | 6,991,003 | 0.0% | 0.12% | -35.9% |
| Q3 2022 | $9,018,000 | +48.3% | 6,991,003 | 0.0% | 0.19% | +18.5% |
| Q2 2022 | $6,082,000 | -71.2% | 6,991,003 | 0.0% | 0.16% | -64.9% |
| Q1 2022 | $21,113,000 | -41.4% | 6,991,003 | 0.0% | 0.46% | -27.4% |
| Q4 2021 | $36,004,000 | -78.7% | 6,991,003 | 0.0% | 0.64% | -72.9% |
| Q3 2021 | $169,392,000 | +24.1% | 6,991,003 | 0.0% | 2.35% | +7.1% |
| Q2 2021 | $136,534,000 | +146.7% | 6,991,003 | +133.7% | 2.19% | +162.7% |
| Q1 2021 | $55,337,000 | – | 2,991,208 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 597,678 | $771,000 | 0.24% |
| Kynam Capital Management, LP | 739,649 | $954,000 | 0.20% |
| RA Capital Management | 6,991,003 | $9,018,000 | 0.19% |
| Octagon Capital Advisors LP | 450,000 | $581,000 | 0.10% |
| Ikarian Capital, LLC | 219,501 | $283,000 | 0.06% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 613,931 | $792,000,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,277,519 | $1,648,000 | 0.00% |
| ROCKY MOUNTAIN ADVISERS, LLC | 1,200 | $2,000 | 0.00% |
| CSS LLC/IL | 38,721 | $50,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $35,000 | 0.00% |